|
Metastatic Brain Tumor Global Clinical Trials Review, H1, 2012
|
|||||||||||
| Preis** (Lieferformat): |
Versandkostenfrei ** WICHTIG: Alle Preise sind netto ausgewiesen. Abhängig von Versand- und Leistungsort ist hierauf noch USt. zu entrichten (Deutschland z.Z. 19%). Der korrekte Gesamtendpreis wird Ihnen mit der Angabe Ihrer Rechnungsadresse, USt-ID-Nr. etc. im Bestellverlauf ausgewiesen. Weitere Informationen zu den Bestandteilen des Kaufpreises finden Sie in unseren FAQs. |
Zahlen und Fakten zur Studie: | 80 seiten | |||||||||
| Inhalt der Studie: |
Introduction
GlobalData's clinical trial report, “Metastatic Brain Tumor Global Clinical Trials Review, H1, 2012" provides data on the Metastatic Brain Tumor clinical trial scenario. This report prov.....
Introduction GlobalData's clinical trial report, “Metastatic Brain Tumor Global Clinical Trials Review, H1, 2012" provides data on the Metastatic Brain Tumor clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Metastatic Brain Tumor. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Metastatic Brain Tumor. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts. Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations - Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type - Listings of discontinued trials (suspended, withdrawn and terminated) Highlights Reasons to buy - Understand the dynamics of a particular indication in a condensed manner - Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more - Obtain discontinued trial listing for trials across the globe - Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies [Studien Infos ausblenden] |
|||||||||||
|
Table of Contents Table of Contents 2 List of Tables 4 List of Figures 5 Introduction 6 Metastatic Brain Tumor 6 Report Guidance 6 Clinical Trials by Region 7 Clinical Trials by Country 8 Top Countries Contributing to Clinical Trials in Asia-Pacific 10 Top Five Countries Contributing to Clinical Trials in Europe 11 Top Countries Contributing to Clinical Trials in North America 12 Top Countries Contributing to Clinical Trials in Central and South America 13 Clinical Trials by BRIC Nations 14 Clinical Trials by G7 Nations 15 Clinical Trials in G7 Nations by Trial Status 16 Clinical Trials by E7 Nations 17 Clinical Trials in E7 Nations by Trial Status 18 Clinical Trials by Phase 19 In Progress Trials by Phase 20 Clinical Trials by Trial Status 21 Unaccomplished Trials of Metastatic Brain Tumor 22 Subjects Recruited Over a Period of Time 23 Prominent Sponsors 24 Prominent Drug Comparison 26 Clinical Trial Profiles 27 Clinical Trial Overview of Top Companies 27 GlaxoSmithKline plc 27 Clinical Trial Overview of GlaxoSmithKline plc 27 Clinical Trial Overview of Top Universities / Institutes / Hospitals 28 Duke University 28 Clinical Trial Overview of Duke University 28 Case Comprehensive Cancer Center 29 Clinical Trial Overview of Case Comprehensive Cancer Center 29 The University of Utah 30 Clinical Trial Overview of The University of Utah 30 Wake Forest University 31 Clinical Trial Overview of Wake Forest University 31 Masonic Cancer Center 32 Clinical Trial Overview of Masonic Cancer Center 32 Abramson Cancer Center 33 Clinical Trial Overview of Abramson Cancer Center 33 St. Mary's Hospital 34 Clinical Trial Overview of St. Mary's Hospital 34 Samsung Medical Center 35 Clinical Trial Overview of Samsung Medical Center 35 University of Colorado 36 Clinical Trial Overview of University of Colorado 36 Yale University 37 Clinical Trial Overview of Yale University 37 Burzynski Research Institute, Inc. 38 Clinical Trial Overview of Burzynski Research Institute, Inc. 38 Memorial Sloan Kettering Cancer Center 39 Clinical Trial Overview of Memorial Sloan Kettering Cancer Center 39 The University of Chicago 40 Clinical Trial Overview of The University of Chicago 40 Federation Nationale des Centres de Lutte Contre le Cancer 41 Clinical Trial Overview of Federation Nationale des Centres de Lutte Contre le Cancer 41 Roswell Park Cancer Institute 42 Clinical Trial Overview of Roswell Park Cancer Institute 42 Emory University 43 Clinical Trial Overview of Emory University 43 University of Medicine and Dentistry New Jersey 44 Clinical Trial Overview of University of Medicine and Dentistry New Jersey 44 Massachusetts General Hospital 45 Clinical Trial Overview of Massachusetts General Hospital 45 University of California, San Francisco 46 Clinical Trial Overview of University of California, San Francisco 46 University Hospital, Bonn 47 Clinical Trial Overview of University Hospital, Bonn 47 Five Key Clinical Profiles 48 Appendix 77 Abbreviations 77 Definitions 77 Research Methodology 78 Secondary Research 78 About GlobalData 79 Contact Us 79 Disclaimer 79 Source 80 [Inhaltsverzeichnis ausblenden] |
||||||||||||
|
List of Tables Metastatic Brain Tumor Therapeutics Market, Global, Clinical Trials by Zone, 2012* 7 Metastatic Brain Tumor Therapeutics Market, Global, Clinical Trials by Top Countries, 2012* 8 Metastatic Brain Tumor Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012* 9 Metastatic Brain Tumor Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2012* 10 Metastatic Brain Tumor Therapeutics Clinical Trials, Europe, Top Five Countries, 2012* 11 Metastatic Brain Tumor Therapeutics Clinical Trials, North America, Top Countries, 2012* 12 Metastatic Brain Tumor Therapeutics Clinical Trials, Central and South America, Top Countries, 2012* 13 Metastatic Brain Tumor Therapeutics Clinical Trials, BRIC Countries, 2012* 14 Metastatic Brain Tumor Therapeutics Clinical Trials, G7 Countries, 2012* 15 Metastatic Brain Tumor Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012* 16 Metastatic Brain Tumor Therapeutics Clinical Trials, E7 Countries, 2012* 17 Metastatic Brain Tumor Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012* 18 Metastatic Brain Tumor Therapeutics Market, Global, Clinical Trials by Phase, 2012* 19 Metastatic Brain Tumor Therapeutics Market, Global, Clinical Trials In Progress by Phase 2012* 20 Metastatic Brain Tumor Therapeutics Market, Global, Clinical Trials by Trial Status, 2012* 21 Metastatic Brain Tumor Therapeutics Market, Global, Terminated Clinical Trials, 2012* 22 Metastatic Brain Tumor Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010 23 Metastatic Brain Tumor Therapeutics Clinical Trials, Global, Key Sponsors, 2012* 25 Metastatic Brain Tumor Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012* 26 Metastatic Brain Tumor Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2012* 27 Metastatic Brain Tumor Therapeutics Clinical Trials Market, Global, Clinical Trials by Duke University, 2012* 28 Metastatic Brain Tumor Therapeutics Clinical Trials Market, Global, Clinical Trials by Case Comprehensive Cancer Center, 2012* 29 Metastatic Brain Tumor Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Utah, 2012* 30 Metastatic Brain Tumor Therapeutics Clinical Trials Market, Global, Clinical Trials by Wake Forest University, 2012* 31 Metastatic Brain Tumor Therapeutics Clinical Trials Market, Global, Clinical Trials by Masonic Cancer Center, 2012* 32 Metastatic Brain Tumor Therapeutics Clinical Trials Market, Global, Clinical Trials by Abramson Cancer Center, 2012* 33 Metastatic Brain Tumor Therapeutics Clinical Trials Market, Global, Clinical Trials by St. Mary's Hospital, 2012* 34 Metastatic Brain Tumor Therapeutics Clinical Trials Market, Global, Clinical Trials by Samsung Medical Center, 2012* 35 Metastatic Brain Tumor Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Colorado, 2012* 36 Metastatic Brain Tumor Therapeutics Clinical Trials Market, Global, Clinical Trials by Yale University, 2012* 37 Metastatic Brain Tumor Therapeutics Clinical Trials Market, Global, Clinical Trials by Burzynski Research Institute, Inc., 2012* 38 Metastatic Brain Tumor Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2012* 39 Metastatic Brain Tumor Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Chicago, 2012* 40 Metastatic Brain Tumor Therapeutics Clinical Trials Market, Global, Clinical Trials by Federation Nationale des Centres de Lutte Contre le Cancer, 2012* 41 Metastatic Brain Tumor Therapeutics Clinical Trials Market, Global, Clinical Trials by Roswell Park Cancer Institute, 2012* 42 Metastatic Brain Tumor Therapeutics Clinical Trials Market, Global, Clinical Trials by Emory University, 2012* 43 Metastatic Brain Tumor Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Medicine and Dentistry New Jersey, 2012* 44 Metastatic Brain Tumor Therapeutics Clinical Trials Market, Global, Clinical Trials by Massachusetts General Hospital, 2012* 45 Metastatic Brain Tumor Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, San Francisco, 2012* 46 Metastatic Brain Tumor Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospital, Bonn, 2012* 47 List of Figures Metastatic Brain Tumor Therapeutics Market, Global, Clinical Trials by Zone (%), 2012* 7 Metastatic Brain Tumor Therapeutics Market, Global, Clinical Trials by Top Countries, 2012* 8 Metastatic Brain Tumor Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012* 9 Metastatic Brain Tumor Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2012* 10 Metastatic Brain Tumor Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2012* 11 Metastatic Brain Tumor Therapeutics Clinical Trials, North America, Top Countries (%), 2012* 12 Metastatic Brain Tumor Therapeutics Clinical Trials, G7 Countries (%), 2012* 15 Metastatic Brain Tumor Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012* 16 Metastatic Brain Tumor Therapeutics Clinical Trials, E7 Countries (%), 2012* 17 Metastatic Brain Tumor Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012* 18 Metastatic Brain Tumor Therapeutics Market, Global, Clinical Trials by Phase (%), 2012* 19 Metastatic Brain Tumor Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2012* 20 Metastatic Brain Tumor Therapeutics Market, Global, Clinical Trials by Trial Status, 2012* 21 Metastatic Brain Tumor Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010 23 Metastatic Brain Tumor Therapeutics Clinical Trials, Global, Key Sponsors, 2012* 24 Metastatic Brain Tumor Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012* 26 GlobalData Methodology 78 [Tabellenverzeichnis ausblenden] |
||||||||||||
| Hinweis: | * Der Rechnungsbetrag für diese Studie wird in $ (Dollar) ausgewiesen. Kunden aus dem Inland bekommen von uns eine Rechnung in Euro, umgerechnet zum letztwöchigen Schlusskurs | |||||||||||
|
|
||||||||||||
